Purpose We aimed to assess the impact of aerobic exercise (AE) on parameters related to
cardiotoxicity in breast cancer (BC) patients receiving anthracycline or trastuzumab …

Background Cardiotoxicity is a known complication and one of the most adverse effects from
the use of conventional treatments such as anthracyclines and trastuzumab in breast cancer …

Background: we conducted a systematic review and meta-analysis of randomized controlled
trials (RCTs) to evaluate the efficacy of exercise training on cardiac function and circulating …

Background Current anticancer treatments for breast cancer (BC) may cause cardiotoxicity.
This study aimed to investigate the effectiveness of aerobic exercise in mitigating …

Introduction: Breast cancer is the most common cancer in women with a 5-year survival over
90%. However, anthracycline-based chemotherapy causes significant cardiotoxicity often …

Aims Exercise training has been suggested to prevent anthracycline-related cardiac
dysfunction, but clinicalbased evidence is scarce. We investigated the effects of a …

Background Trastuzumab is used, alone or in conjunction with standard chemotherapy, to
treat HER2-positive breast cancer (BC). Although it improves cancer outcomes, trastuzumab …

Physical activity is known to prevent the occurrence of cancer and decrease the risk of
breast cancer. At diagnosis of breast cancer, fewer than half of the patients reach the …

Background Breast cancer (BC) treatment with anthracyclines and/or anti-human epidermal
growth factor receptor-2 (HER2) antibodies is associated with an increased risk of …

While developments in cancer therapeutics have greatly reduced morbidity and mortality in
females with breast cancer, it comes at a cost of an increased risk of cardiovascular …